Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response - 04/09/11
Abstract |
Background: Toxic epidermal necrolysis is a severe reaction with skin involvement induced by different drugs and other agents. The mechanisms implicated in the induction of the reaction are poorly understood. Objective: Our purpose was to study the involvement of T lymphocytes and other immunocompetent cells in the peripheral blood, blister fluid, and affected skin of 3 patients who had a severe reaction after receiving anticonvulsant medication. Methods: Quantification of T lymphocytes expressing the skin-homing receptor (cutaneous lymphocyte-associated antigen [CLA]) in peripheral blood, skin, and skin blister fluid and assessment of other adhesion molecules, activation markers, and inflammatory interleukins by flow cytometry, immunohistochemistry, and reverse transcription–PCR. Results: An increase in CD3+CLA+ cells paralleling the severity of the disease was observed in both peripheral blood and skin, tending to normalize as soon as patient’s conditions improved. E-selectin was detected in endothelial vessels in parallel with CLA expression on lymphocytes. An overexpression of TNF⍺, IFN-γ, and IL-2 was also observed in PBMCs. The expression of the different markers changed over the course of the disease. Conclusions: These data show an increase in activated T cells expressing the skin-homing receptor in both tissue and peripheral blood accompanying clinical symptoms, with a recruitment of macrophages and an overexpression of cytokines. All these results suggest an important role for T cells in the production of toxic epidermal necrolysis. (J Allergy Clin Immunol 2000;105:157-65.)
El texto completo de este artículo está disponible en PDF.Keywords : Toxic epidermal necrolysis, anticonvulsant, severe skin reactions, T lymphocytes, cutaneous lymphocyte-associated antigen, homing, cytokines
Abbreviations : CLA:, GC:, GR:, ICAM-1:, mRNA:, PE:, PerCP:, RT-PCR:, SBAP:, TEN:, VCAM-1:
Esquema
Supported in part by grants No. CICYT SAF 96/0240 from the Consejería de Salud de la Junta de Andalucía and No. Fondo de Investigaciones Sanitarias 98/0861. L. L. has FIS fellowship No. 98/5061. |
|
Reprint requests: Carlos Juárez, MD, PhD, Internal Medicine Department, “Carlos Haya” Hospital Complex, Avda Carlos Haya, Malaga 29010, Spain. |
|
0091-6749/2000 $12.00 + 0 1/1/103417 |
Vol 105 - N° 1P1
P. 157-165 - janvier 2000 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?